Jeremy Rohen
Known title: SVP, Strategy & Business DevCIK: 0001848173
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating. UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.
Transaction History
| ACNT | ▲ Buy | Grant | 4,783 | $65K | 6/10/2026 | View on chart |
| ACNT | ▲ Buy | Grant | 2,159 | $29K | 4/1/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 3,046 | — | 1/18/2023 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 1,688 | $46K | 1/18/2023 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 1,922 | — | 3/3/2022 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 631 | $16K | 3/3/2022 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 3,045 | — | 1/18/2022 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 1,176 | $38K | 1/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Ascent Industries faces scrutiny on cash flow and profitability
A recent analysis highlighted that while Ascent Industries has potential, it needs to improve its cash flow and profitability. This commentary is relevant as the stock trades with a high trailing P/E ratio of 112.2, suggesting investors are pricing in significant future growth. The stock is currently near its support level, reflecting cautious sentiment.
Ascent Industries faces scrutiny on cash flow and profitability. A recent analysis highlighted that while Ascent Industries has potential, it needs to improve its cash flow and profitability. This commentary is relevant as the stock trades with a high trailing P/E ratio of 112.2, suggesting investors are pricing in significant future growth. The stock is currently near its support level, reflecting cautious sentiment.